Reimagining cancer therapy
with precision & hope.
TumorSelect® is an innovative drug delivery platform designed to deliver chemotherapy directly to cancer cells while sparing healthy tissue.
The science behind the hope.
Curious how it works? TumorSelect® cloaks chemotherapy in a natural disguise, allowing it to bypass healthy cells and release its power only inside tumors.
How We Target Only Cancer Cells
Traditional chemotherapy affects the whole body, but TumorSelect® is different. It recognizes the unique biology of cancer cells and directs treatment precisely where it’s needed, leaving healthy cells largely untouched.
How We Cloak the Therapy
TumorSelect® disguises the medicine by mimicking natural cholesterol (LDL) that cancer cells crave. This “cloak” allows the therapy to move safely through the body and slip past normal defenses until it reaches the tumor.
Why the Treatment Activates Only Inside Tumors
The drug stays inactive until it enters the special environment inside cancer cells. Only then does it unlock, ensuring the therapy works exactly where it’s needed — not in healthy tissues.
How the Drug Is Released at the Right Time
Once inside the tumor, the disguise breaks down and the medicine is released. This direct approach maximizes its cancer-fighting power while greatly reducing harmful side effects.
LDL-Mimicking Nanoparticles
Built-In Precision
Cancer-Selective Uptake
Triggered Release
Our mission
To use our proprietary LDL technology to create new chemotherapeutics that selectively target tumors and thereby improve tolerability and efficacy of known molecules as well as enable novel ones.
Our vision
To transform cancer treatment by providing a targeted, effective, and patient-friendly solution. TumorSelect® is designed to save lives by selectively attacking cancer cells while preserving healthy tissue, reducing the debilitating side effects of traditional therapies.
Who we are.
Cloaked Therapeutics is a private biopharmaceutical company dedicated to transforming the way cancer is treated. Founded in 2014 and built on discoveries from Veiled Therapeutics, our work centers on TumorSelect® — a proprietary technology that delivers chemotherapy directly into tumor cells while protecting healthy tissue.
By mimicking natural LDL particles, TumorSelect® allows anticancer agents to slip past normal defenses and concentrate inside tumors. This targeted approach is designed to boost effectiveness, reduce toxicity, and give patients safer, more tolerable treatment options.
Our lead program uses TumorSelect® to improve delivery of paclitaxel, one of the most widely used chemotherapies. Early results show the potential to not only enhance its cancer-fighting power but also lessen the harsh side effects seen with traditional and newer formulations.
Imagine a future where cancer treatment heals without harm. Share our mission and inspire others to join the movement.